Ancora.ai AG

Ancora.ai connects patients to clinical trials

Finding a clinical trial for a cancer patient demands extraordinary effort as it requires evaluating many available trial opportunities against specific patient characteristics. Ancora.ai accelerates clinical trial recruitment by systematically and seamlessly connecting patients to trials. Our proprietary technology structures jargon-laden clinical trial protocols into an easy to use interface to match any patient to trials at scale. Our best-in-class trial matching solution means we can more efficiently and effectively match highly qualified patients to the right trials, thereby transforming the $44B. clinical research industry to be data-driven & enabling precision medicine recruitment.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
Deal

01.07.2023

Achieved First Top 10 Pharma Contract

Milestone

31.10.2022

Neuroendocrine Tumor Trial Finder Funding

Deal

01.10.2021

Preseed Round

Show more...

No Jobs

No videos and documents

Venture Leaders Mobile

The Venture Leaders - as members of the Swiss National Startup Team - have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The Venture Leaders’ startup development program is specifically structured to help them achieve these goals. Each year, the Venture Leaders Mobile journey offers selected entrepreneurs an accelerated learning curve and a solid network through their participation at the Mobile World Congress and 4YFN Conference.

Website

Ancora.ai AG

Ancora.ai connects patients to clinical trials

Headquarter:
Zurich

Foundation Date:
June 2020

Technology:

  • ICT

Sectors:

  • Cancer
  • Digital Health
  • Machine Learning / AI
  • Research and development
  • Software

Support received

  • Support venture leaders